Previous close | 0.0006 |
Open | 0.0007 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's range | 0.0007 - 0.0007 |
52-week range | 0.0003 - 0.0018 |
Volume | |
Avg. volume | 3,478,227 |
Market cap | 6.748M |
Beta (5Y monthly) | -0.11 |
PE ratio (TTM) | 0.07 |
EPS (TTM) | 0.0100 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
HOUSTON, TX , Dec. 06, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Cannabis Bioscience International Holdings, Inc. (OTC Pink: CBIH) announces that its registration statement on Form S-1 (File No. 333-267039) (the “Registration Statement”), filed under the Securities Act of 1933 (the “Securities Act”), was declared effective by the United States Securities and Exchange Commission (the “SEC”) on December 5, 2023. This declaration does not imply that the SEC has approved or disapproved the offer o
HOUSTON, Texas, Aug. 21, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Cannabis Bioscience International Holdings (the “Company”) a diversified medical and educational company with a particular focus on traditional clinical trials and cannabinoids research, is excited to announce that FINRA (Financial Industry Regulatory Authority, Inc.) has approved the corporate name change from “China Infrastructure Construction Corp.” to “Cannabis Bioscience International Holdings” as well as its ticker symbo